Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes H Kaur, N Shekhar, S Sharma, P Sarma, A Prakash, B Medhi Pharmacological Reports 73, 736-749, 2021 | 117 | 2021 |
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2 M Prajapat, N Shekhar, P Sarma, P Avti, S Singh, H Kaur, ... Journal of Molecular Graphics and Modelling 101, 107716, 2020 | 75 | 2020 |
MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy GB Singh, SK Raut, S Khanna, A Kumar, S Sharma, R Prasad, M Khullar Molecular and cellular biochemistry 424, 1-11, 2017 | 61 | 2017 |
COVID-19–associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis A Bhattacharyya, P Sarma, H Kaur, S Kumar, J Bhattacharyya, M Prajapat, ... Indian Journal of Pharmacology 53 (6), 499-510, 2021 | 39 | 2021 |
Catestatin Gly364Ser variant alters systemic blood pressure and the risk for hypertension in human populations via endothelial nitric oxide pathway M Kiranmayi, VR Chirasani, PKR Allu, L Subramanian, EE Martelli, ... Hypertension 68 (2), 334-347, 2016 | 37 | 2016 |
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review H Kaur, P Sarma, A Bhattacharyya, S Sharma, N Chhimpa, M Prajapat, ... European journal of pharmacology 906, 174233, 2021 | 31 | 2021 |
Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis A Bhattacharyya, S Kumar, P Sarma, H Kaur, M Prajapat, N Shekhar, ... Indian journal of pharmacology 52 (4), 313-323, 2020 | 30 | 2020 |
Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis P Sarma, A Bhattacharyya, H Kaur, M Prajapat, A Prakash, S Kumar, ... Indian journal of pharmacology 52 (6), 535-550, 2020 | 29 | 2020 |
Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings P Avti, A Chauhan, N Shekhar, M Prajapat, P Sarma, H Kaur, ... Journal of Biomolecular Structure and Dynamics 40 (19), 8894-8904, 2022 | 24 | 2022 |
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics … N Shekhar, P Sarma, M Prajapat, P Avti, H Kaur, A Raja, H Singh, ... Msystems 5 (5), 10.1128/msystems. 00382-20, 2020 | 23* | 2020 |
Valproic acid and propionic acid modulated mechanical pathways associated with autism spectrum disorder at prenatal and neonatal exposure AR Sharma, G Batra, L Saini, S Sharma, A Mishra, R Singla, A Singh, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 22 | 2022 |
Indian contribution toward biomedical research and development in COVID-19: A systematic review H Kaur, M Kaur, A Bhattacharyya, M Prajapat, P Thota, P Sarma, S Kumar, ... Indian Journal of Pharmacology 53 (1), 63-72, 2021 | 16 | 2021 |
Update on geographical variation and distribution of SARS-nCoV-2: A systematic review M Prajapat, V Handa, P Sarma, A Prakash, H Kaur, S Sharma, ... Indian Journal of Pharmacology 53 (4), 310-316, 2021 | 11 | 2021 |
DUSP-1 gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy GB Singh, S Khanna, SK Raut, S Sharma, R Sharma, M Khullar Therapeutic Advances in Cardiovascular Disease 11 (5-6), 147-154, 2017 | 11 | 2017 |
A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders L Subramanian, AA Khan, PKR Allu, M Kiranmayi, BS Sahu, S Sharma, ... Journal of Biological Chemistry 292 (34), 13970-13985, 2017 | 10 | 2017 |
Yogic Neti-Kriya Using Povidone Iodine: Can it have a Preventive Role Against SARS-CoV-2 Infection Gateway? PABM Phulen Sarma, Anusuya Bhattacharyya, Ajay Prakash, Hardeep Kaur ... Indian Journal of Otolaryngology and Head & Neck Surgery, 1-7, 2021 | 8 | 2021 |
A Common Tag Nucleotide Variant in MMP7 Promoter Increases Risk for Hypertension via Enhanced Interactions With CREB (Cyclic AMP Response Element … L Subramanian, S Maghajothi, M Singh, K Kesh, A Kalyani, S Sharma, ... Hypertension 74 (6), 1448-1459, 2019 | 8 | 2019 |
An insight into the simulation directed understanding of the mechanism in SARS CoV-2 N-CTD, dimer integrity, and RNA-binding: Identifying potential antiviral inhibitors A Chauhan, PK Avti, N Shekhar, M Prajapat, P Sarma, N Sangwan, ... Journal of Biomolecular Structure and Dynamics 40 (24), 13912-13924, 2022 | 5 | 2022 |
Functional Gly297ser variant of the physiological dysglycemic peptide pancreastatin is a novel risk factor for cardiometabolic disorders PKR Allu, M Kiranmayi, SD Mukherjee, VR Chirasani, R Garg, ... Diabetes 71 (3), 538-553, 2022 | 5 | 2022 |
Pharmacogenetics of essential hypertension M Khullar, S Sharma Genetics and Pathophysiology of Essential Hypertension, 195-210, 2012 | 5 | 2012 |